Clinical Trial Update: Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine [Phase 1]

View source ↗

Summary

This trial update reports the completion of a Phase I study evaluating the safety and preliminary efficacy of an HBV DNA vaccine in chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HBV DNA vaccine (HBV DNA vaccine)

Snippet

Sponsor: Genexine, Inc. | Conditions: Chronic Hepatitis B | Phase 1 | Status: COMPLETED